Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis greenmarketreport Views: 600

-

The hydroponic store chain GrowGeneration Corp. (NASDAQ: GRWG) is making a big bet on the Arizona market. The company announced that it was buying Hydroponics Depot, Phoenix’s largest indoor and outdoor garden center. The company did not disclose how much was paid for the company and whether the deal was stock or cash or a combination.

The acquisition of Hydroponics Depot brings GrowGen’s portfolio of hydroponic garden centers to 29 stores across 11 states. “We’re excited to add Hydroponics Depot to our growing portfolio, with year-to-date sales in excess of $5 million and year-over-year growth at 50 percent,” said Tony Sullivan, GrowGen’s COO. “Importantly, it represents our 11th state and our first retail operation in Arizona, a key market in GrowGen’s growth plan. We see tremendous potential from both a medical and recreational standpoint.”

-

GrowGen pointed out that its entry into the Arizona market comes as voters consider Prop 207, which would legalize limited possession, cultivation, and use of marijuana for adults ages 21 years or older. If approved, it is estimated that Arizona’s cannabis market could grow from over a $700 million market in 2020 into a $2 billion market, including both recreational and medical marijuana. Retail sales of medical marijuana products in the state rose nearly 20% from January to May, according to the Arizona state estimates.

Hindenburg Research Fallout

The company has been relatively quiet since August’s report from well-known short-seller Hindenburg Research that questioned the company’s management team in a report. The company has chosen several cannabis companies over the years to write damning reports typically after the company has shorted shares with the goals of making existing shareholders sell. Then Hindenburg buys back the stock to cover its short at the lower price and thus making a profit.

The report doesn’t find fault with the company’s financial statements and indeed calls the company’s latest quarter “impressive” and called the business model”interesting.” It takes issue with the price of the shares being overvalued and felt that there should be a correction in the price of the company stock. However, it saved most of its criticism for the company’s executive team, which it accuses of having unsavory ties to past criminal behavior involving stock fraud.

GrowGeneration said it planned to take action against Hindenburg. Schall Legal firm had planned to investigate claims against GrowGeneration, but following a letter from GrowGeneration has had a change of heart and announced at the end of August it was no longer pursuing that investigation.

The stock fell from a year’s high of $22.88 following the report, but was beginning to recover and was lately trading at $18.86 as the stock moved higher in early trading on the news of the Arizona acquisition.

GrowGeneration Jumps Into Arizona on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.